Viewing Study NCT06538558


Ignite Creation Date: 2025-12-25 @ 12:12 AM
Ignite Modification Date: 2026-01-25 @ 7:38 AM
Study NCT ID: NCT06538558
Status: RECRUITING
Last Update Posted: 2024-11-06
First Post: 2024-07-31
Is Gene Therapy: True
Has Adverse Events: False

Brief Title: Study to Assess the Use of Tezampanel for Opioid Withdrawal Syndrome in Treatment-Seeking Patients With Opioid Use Disorder
Sponsor: Proniras Corporation
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module